What “Evidence-Based” and “Evidence-Guided” Mean in Marketing Copy

Neither phrase is an FDA approval category or an FTC certification. Neither is a status a practice applies for and is granted, in the way a product is approved or a device is cleared, which is what the words can sound like when they appear beside regulatory language.

The phrases are not certifications. The claim sitting underneath them is still regulated, and that gives you something concrete to ask for.

Neither phrase is a defined certification

This page does not define evidence-based clinical practice, and it is worth saying so at the start rather than gesturing at a definition we have not sourced. The question here is narrower: what do these phrases establish when they appear in marketing copy? In that setting the phrase functions as an adjective, and whatever method might sit behind it is not visible to you.

“Evidence-guided” is looser still. It suggests a relationship to evidence without stating what the relationship is. A practice could describe itself this way while reading the literature carefully, or while reading a manufacturer’s brochure. The phrase does not distinguish between the two.

Neither term tells you which evidence, for which condition, at what stage, in how many people. Those four gaps are what the rest of this page fills.

But the claim behind it is regulated

What is not optional is the accuracy of the health claim the phrase is attached to. The FTC’s guidance for health products is direct about the standard:

“tests, analyses, research, or studies that (1) have been conducted and evaluated in an objective manner by experts in the relevant disease, condition, or function to which the representation relates; and (2) are generally accepted in the profession to yield accurate and reliable results.”

Source: FTC, Health Products Compliance Guidance. Accessed 18 September 2026.

That is the definition of what the FTC calls competent and reliable scientific evidence. The guidance adds a second requirement about how much of it is needed:

“sufficient in quality and quantity based on standards generally accepted in the relevant scientific fields, when considered in light of the entire body of relevant and reliable scientific evidence, to substantiate that the representation is true.”

Same source.

Read the last clause carefully: the entire body of relevant and reliable scientific evidence. Not the supportive part of it. A single favourable study, presented on its own, cannot be weighed on its own against a standard that asks about the whole body of relevant evidence, because the rest of that body has not been looked at.

What counts, and what does not

The same guidance is explicit about two categories that do not meet the standard.

“Anecdotal evidence about the individual experiences of consumers, including surveys of consumer experiences, are never sufficient to substantiate claims”

“Animal and in vitro studies…aren’t sufficient to substantiate health-related claims”

Same source.

Those two sentences cover two kinds of support you may be shown. Patient stories, however genuine, do not substantiate a health claim. Laboratory and animal work, however interesting, does not substantiate a health claim about people.

The guidance describes randomized controlled human trials as the most reliable form of substantiation, and allows high quality epidemiologic evidence to substitute only in narrow circumstances:

“in those limited cases where: 1) it is considered an acceptable substitute for RCTs by experts in the field; and 2) RCTs aren’t otherwise feasible.”

Same source.

Four questions that turn the phrase into a claim

The phrase itself cannot be checked. A claim can. These four questions convert one into the other.

Which evidence? Ask for the specific studies or documents. A name, a journal, a year, or a registry number. If the answer is a general statement about the field, you have not yet received an answer.

For which condition? Evidence for one use does not automatically substantiate a different indication or a different population. A study in one population and one indication says nothing directly about a different one.

At what stage? Where a study carries a phase designation, the phase tells you what it was built to establish rather than what it showed. This page does not set out what each phase is for; our page on reading a cited study quotes FDA’s own descriptions and covers the case where a study has no phase at all.

In how many people? And how many completed it. Size on its own is not quality, but it bounds what the result can support.

Write the four answers down. If any of them cannot be answered, that is a finding, and it is a more useful one than a promise.

Who is responsible for the claim

This matters because it tells you who is accountable for what you are being told.

“Anyone participating in deceptive marketing is potentially liable under FTC law.”

Same source.

The guidance describes that responsibility as reaching beyond the marketer of a product to include, among others, corporate officers, ad agencies, distributors, retailers and expert endorsers. It also states that an advertiser remains responsible for claims made on its behalf by others.

Read the scope of that sentence carefully, because it is narrower than it first sounds and the narrowness is the point. It attaches to participating in deceptive marketing, and it says potentially liable. It is not a rule that everyone who describes a treatment carries legal responsibility for the description.

What it does mean is that a party who takes part in making marketing claims can bear responsibility for them without having manufactured anything. So “we only provide the treatment, the claims come from the supplier” is not, on the face of this sentence, a complete answer; but whether it holds in any particular case is a legal question and not one this page answers.

What a complete answer sounds like

A complete answer is not an enthusiastic one. It is a specific one. It names the evidence, states the indication it covers, identifies the stage and the size, and is willing to be written down.

An incomplete answer repeats the phrase in different words. If you ask which evidence and receive the response that the approach is evidence-guided, you have received the question back.

Neither response tells you whether a treatment will help you. What the complete one gives you is something you can take away and check.

---

Where to go from here

If the answer to your four questions is a study, the next step is Reading the Study a Clinic Shows You. If the answer is a patient story, that belongs in a different category: Testimonials and Outcome Stories: Where They Sit in the Evidence Ladder.

Before you leave this page: write the four questions on the same sheet you will take to your appointment, and leave space for the answers.

---

What this does not mean

This page does not suggest that a practice using these phrases is being deceptive, and it makes no claim about anyone’s intent, which it has no way of knowing. It describes what the phrases do and do not establish, and what the law requires of the claim underneath them. It does not evaluate any practice, any product or any individual case.

---

One source, six quotations. This page rests on a single document, and every passage in quotation marks above is from it. That is a narrow evidence base and we would rather you saw it than inferred it. Open the guidance and read the substantiation section in full; it is more specific than any summary of it, including ours.

• FTC · Health Products Compliance Guidance · accessed 18 September 2026

Written and fact-checked against the sources above on 18 September 2026. No independent expert review has taken place yet, and this page says so rather than implying one. This page is reviewed every twelve months.